Share Twitter LinkedIn Facebook Email Andrew Chi, MD, PhD at NYU Langone Medical Center Explains how Gliomas in Mid-Line Locations are Distinct in Both Genetic Makeup and Behavior. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read